Celebrex: On-going trials with COX2 inhibitors

December 2004

By: Linda Wilhelm and Anne Dooley

Published under: Access to Medications | CAPA Voices December 2004

Tools: comments (0) | forward to a friend | print article

Data from one of two cancer studies indicates an increased risk of cardiovascular problems in patients taking Celebrex - the second study shows no increase.

Comments

no comments so far

You must register and log-in to add a comment.

Comments are moderated and generally will be posted if they are on-topic and not abusive.

Celebrex: On-going trials with COX2 inhibitors

Comments

Leave a Comment